WINMILIA Trademark

Trademark Overview


On Tuesday, March 6, 2018, a trademark application was filed for WINMILIA with the United States Patent and Trademark Office. The USPTO has given the WINMILIA trademark a serial number of 87822338. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 28, 2025. This trademark is owned by Glaxo Group Limited. The WINMILIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
winmilia

General Information


Serial Number87822338
Word MarkWINMILIA
Filing DateTuesday, March 6, 2018
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 28, 2025
Registration Number5748529
Registration DateTuesday, May 14, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 22, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 28, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, March 9, 2018NEW APPLICATION ENTERED
Tuesday, March 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 18, 2018ASSIGNED TO EXAMINER
Monday, June 18, 2018SUSPENSION LETTER WRITTEN
Monday, June 18, 2018LETTER OF SUSPENSION E-MAILED
Monday, June 18, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, November 27, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, November 30, 2018ASSIGNED TO LIE
Thursday, December 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 13, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 2, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 22, 2019PUBLISHED FOR OPPOSITION
Tuesday, January 22, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 21, 2019TEAS DELETE 1(B) BASIS RECEIVED
Thursday, April 11, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 21, 2019NOTICE OF ALLOWANCE CANCELLED
Thursday, April 11, 20191(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, May 14, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 9, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 9, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 14, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, November 28, 2025CANCELLED SEC. 8 (6-YR)